News

GOOD LUCK TO ALICIA. Alisha McDevitt, longtime news director of WMUR-TV, the Hearst Television ABC affiliate in Manchester, New Hampshire, has been promoted to WMUR president and general manager ...
Soccer star Alisha Lehmann had a head-turning moment at the Baller League UK that had fans talking. Combining high fashion with her signature confidence, the Swiss player—often dubbed the ...
Juventus star Alisha Lehmann has been blasted by fans on social media after the Serie A Women's side won the title. Back in July, Lehmann and long-term boyfriend Douglas Luiz both left Aston Villa to ...
Juventus Women forward Alisha Lehmann claims that her Bianconeri teammate and Italy international Sofia Cantore ‘will become the best in the world one day’ while celebrating the team’s ...
The Sarnia Sting didn’t expect Easton Wainwright to leave so soon for the NCAA. Neither did Wainwright. However, Colgate University’s offer was too good to turn down, so the veteran forward is ...
Albert Wainwright’s remarkable and graphic 1920s sketchbooks captured Anglo-German relations between the wars and the gay culture of that period “..Wainwright can be said to incorporate elements of ...
Alisha Lehmann has come in for criticism from fans claiming her role in Juventus' title celebrations is not exactly proportionate to the part she played in securing the silverware. Lehmann ...
H.C. Wainwright has a Buy rating and $120 price target on Cytokinetics shares. Discover outperforming stocks and invest smarter with Top Smart Score Stocks. Filter, analyze, and streamline your ...
Wednesday, H.C. Wainwright upgraded Dogwood Therapeutics, Inc. (NASDAQ:DWTX) from Neutral to Buy, significantly increasing the price target to $10.00 from the previous $5.00. The stock has shown ...
“That’s a pretty expensive chicken tender and fry for Adam Wainwright’s dollar,” Benetti said. “I missed it, what was it?” Wainwright replied. “$16.39,” Benetti answered.
On Wednesday, H.C. Wainwright initiated coverage on Oklo Inc. (NYSE: OKLO), a company specializing in advanced nuclear technology, with a Buy rating and a price target of $55.00. Trading at $21.53 ...